Antibodies to watch in 2024

(1:9:35)

Emerging Therapies: Antibody Drug Conjugates and Radiopharmaceuticals - LCVL 2024

(2:)

Insights from antibody-drug conjugate research at SABCS 2024

(1:39)

2024 Antibody Engineering \u0026 Therapeutics Presentation by Luciana K. Rosselli-Murai, PhD

(19:)

The future of antibody-drug conjugates in endometrial cancer

(1:43)

2024 Antibody Engineering \u0026 Therapeutics Presentation by Hui Foon Tan, PhD \u0026 Stuart A. Sievers, PhD

(43:15)

AET London 2024: Bispecific Antibody Therapeutics: Challenges, Opportunities and Future Directions

(22:29)

Antibody-Drug Conjugates in Specific Subsets of NSCLC - 2024 Lung Cancer OncTalk

(6:22)

The prevention of antigen escape in B-cell lymphomas treated with bispecific antibodies

(3:15)

Structure and Function of Antibody-Drug Conjugates - 2024 Lung Cancer OncTalk

(4:56)

Bio SB Inc. 2024 New Antibody Launch

(2:33)

Antibody-Drug Conjugates in Small Cell Lung Cancer - 2024 Lung Cancer OncTalk

(3:18)

Immunology Fall 2024: Lecture 9 Antibody Structure and Function

(1:3:2)

Antibody-Drug Conjugates in Unselected Non-Small Cell Lung Cancer - 2024 Lung Cancer OncTalk

(8:43)

Breakthroughs in Antibody Drug Development

(3:28)

Antibody-Drug Conjugates and the Treatment of Small Cell Lung Cancer - 2024 Lung Cancer OncTalk

(2:46)

Biointron Insights: Antibody Industry Report (YTD December 2024 Insights, Trends \u0026 Analysis)

(20:39)

Bispecific Antibodies | New York Roundtable October 19, 2024

(31:50)

Treating RRMM with Bispecific Antibodies | Rakesh Popat, PhD | EHA 2024

(3:9)

Immunology Fall 2024: Lecture 10 Diversity of Antibody Isotypes

(50:47)